Headline
The latest stories from AHA Today.
The Food and Drug Administration issued final guidance for health care providers and researchers using investigational COVID-19 convalescent plasma, defined as convalescent plasma that does not meet all conditions of the agency’s emergency use authorization or which is used under an investigational…
The Department of Health and Human Services has released a PPE Preservation Planning Toolkit to help organizations implement strategies to preserve personal protective equipment during the COVID-19 pandemic.
The AHA, American Medical Association and American Nurses Association urged the Trump administration to share all critical information related to COVID-19 with the Biden transition team.
As we celebrate National Rural Health Day on Nov. 19, it’s important to recognize the work rural hospitals are doing to improve access to maternal care for mothers living in rural communities, writes Priya Bathija, AHA’s vice president of strategic initiatives.
The Cybersecurity and Infrastructure Security Agency, FBI and Department of Health and Human Services said they consider the recent ransomware threat to the health care sector to be credible, ongoing and persistent.
Albert Rizzo, M.D., chief medical officer for the American Lung Association and chief of pulmonary and critical care medicine at ChristianaCare in Newark, Del., will discuss lung cancer screening to reduce mortality during an AHA Physician Alliance webinar Nov. 19 at 1 p.m. ET.
The Federal Trade Commission voted 5-0 to file an administrative complaint and authorize a federal lawsuit to block Memphis-based Methodist Le Bonheur Healthcare from acquiring Saint Francis Hospital-Memphis and Saint Francis Hospital-Bartlett from Tenet Health.
Sarah Krevans, president and CEO of Sutter Health, will join AHA Board Chair Melinda Estes, M.D., Nov. 19 at 3:30 p.m. ET to discuss how hospitals can move from relief, recovery, and rebuilding to reimagining and innovation
Moderna Inc. announced that its mRNA-1273 vaccine candidate against COVID-19 is 94.5% effective, according to early data.
ombating stigma is the missing element to the nation’s response to the addiction crisis, writes Matthew Stefanko, director of National Stigma Initiative for Shatterproof, a national nonprofit dedicated to reversing the addiction crisis in the U.S.